Discover 520 paid clinical trials in Madison, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 520
Active & Responsive
Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)
for
Achondroplasia
Location: Madison WI, Ottawa, Baltimore MD, Montreal, Oakland CA
Location: Madison WI, Fargo ND, Erie PA, Atlanta GA, Dallas TX,
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 50+
Code: NCT06924021
Recruiting
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: Madison WI, Saint Paul MN, Springfield IL,
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Active & Responsive
Lopinavir/Ritonavir in PLWH With High-Grade AIN
for
High-Grade Anal Intraepithelial Neoplasia
Location: Madison WI
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 18+
Code: NCT05334004
Phase 1, Recruiting
Active & Responsive
Cervical Plexus Hydrodissection With D5W Versus NS for Treatment-Resistant PTSD
for
PTSD
Location: Madison WI, Portland OR
Sponsor: Dr. Dean Reeves Clinic
Sex: All
Age: 19 - 70+
Code: NCT07382596
Phase 4, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: Madison WI, Chicago IL, Hammond IN, Rochester MN,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase 3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Madison WI, Chicago IL, Hammond IN, Indianapolis IN,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase 3, Recruiting
Active & Responsive
A Study of Mirikizumab Solution (LY3074828) in Healthy Participants
for
Healthy
Location: Madison WI, Dilworth MN, Dallas TX, San Antonio TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 65
Code: NCT07446101
Phase 1, Recruiting
Active & Responsive
Caris Biorepository Research Protocol
for
Cancer, Early Detection of Cancer, Minimal Residual Disease
Location: Janesville WI, Hinsdale IL, Cleveland OH, Boardman OH,
Sponsor: Caris Science, Inc.
Sex: All
Age: 18+
Code: NCT01499394
Recruiting
Active & Responsive
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Oconomowoc WI, Summit WI, Rockford IL, Mukwonago WI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06589804
Phase 3, Recruiting
Active & Responsive
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
for
Stomatitis
Location: Waukesha WI, Minneapolis MN, Grayling MI, Fort Wayne IN,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07357597
Phase 4, Recruiting
Active & Responsive
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Rockford IL, Carthage IL, Dixon IL, DeKalb IL,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05929768
Phase 3, Recruiting
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
for
Percutaneous Coronary Intervention,
Location: Rockford IL, Milwaukee WI, Park Ridge IL, Green Bay WI,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06909565
Phase 4, Recruiting
Active & Responsive
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
for
Irritable Bowel Syndrome
Location: Rockford IL, Waukesha WI, Milwaukee WI, Peoria IL,
Sponsor: Dynogen Pharmaceuticals
Sex: Female
Age: 18 - 65
Code: NCT00547469
Phase 2, Phase 3, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Rockford IL, Crystal Lake IL, Dixon IL, Grayslake IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase 3, Recruiting
Biomarkers Study in Infants With Prior Neonatal Brain Injury